Family Office Of America (FOFA) Shares Outstanding (Weighted Average) (2021 - 2026)

Family Office Of America's (FOFA) quarterly Shares Outstanding (Weighted Average) came in at $30.2 million in Q1 2026, up 33.87% year-on-year from $22.6 million in Q1 2025, and up 13.39% quarter-over-quarter from $26.7 million in Q4 2025.

Family Office Of America (FOFA) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends

Family Office Of America has disclosed Shares Outstanding (Weighted Average) across 6 years of filings, most recently posting $30.2 million for Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $30.2 million, up 33.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.2 million (up 33.87% YoY), and the FY2025 annual result was $26.7 million, up 31.65% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $30.2 million for Q1 2026 at Family Office Of America, up from $26.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $30.2 million in Q1 2026 to a low of $8.2 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $19.7 million (2024), against an average of $16.3 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) climbed 1.18% in 2023 and surged 141.15% in 2024, its largest moves.
  • Family Office Of America's Shares Outstanding (Weighted Average) stood at $8.3 million in 2022, then rose by 1.71% to $8.5 million in 2023, then soared by 139.06% to $20.3 million in 2024, then soared by 31.65% to $26.7 million in 2025, then gained by 13.39% to $30.2 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $30.2 million (Q1 2026), $26.7 million (Q4 2025), and $25.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 382.90 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 456.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 98.20 Mn
10 Family Office Of America - - 783,126.00 30.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.25 Mn
Dec 31, 2025 26.68 Mn
Sep 30, 2025 25.58 Mn
Jun 30, 2025 24.67 Mn
Mar 31, 2025 22.59 Mn
Dec 31, 2024 20.26 Mn
Sep 30, 2024 20.44 Mn
Jun 30, 2024 20.44 Mn
Mar 31, 2024 19.73 Mn
Dec 31, 2023 8.48 Mn
Sep 30, 2023 8.48 Mn
Jun 30, 2023 8.48 Mn
Mar 31, 2023 8.48 Mn
Dec 31, 2022 8.33 Mn
Sep 30, 2022 8.38 Mn
Jun 30, 2022 8.24 Mn
Mar 31, 2022 8.24 Mn
Dec 31, 2021 6.93 Mn
Sep 30, 2021 6.49 Mn
Jun 30, 2021 6.11 Mn